Reports

Cintas Corporation delivered solid third-quarter results with revenue growing by 8.4% to $2.61 billion and net income increasing by 16.6% to $463.5 million. The company achieved higher gross margins and operating income, demonstrating efficient cost management and operational excellence.

• Revenue grew by 8.4% to $2.61 billion.
• Organic revenue growth rate was 7.9%.

Paychex, Inc. achieved 5% revenue growth in the third quarter of fiscal 2025, driven by strong performances in management solutions and PEO & insurance solutions segments. The company improved both operating margins and EPS, supported by operational efficiencies and strategic investments in technology.

• Revenue increased 5% to $1.509 billion.
• Net income rose 4% to $519.3 million.

Dollar Tree's Q4 2024 results reflected a 0.7% increase in net sales to $4.9967 billion, with same-store net sales growth of 2.0%. Operating income fell by 26.5% to $533.6 million. GAAP EPS from continuing operations was $1.86, and adjusted consolidated EPS was $2.29. The company also reported a gross profit of $1.8798 billion, with a decline in gross margin to 37.6%.

• Net sales increased slightly by 0.7% to $4.9967 billion.
• Operating income decreased by 26.5% to $533.6 million.

Chewy's Q4 2024 earnings showed net sales of $3.25 billion, up 14.9% year-over-year. The company reported a net income of $22.8 million and adjusted net income of $120 million. Gross margin expanded to 28.5%, while free cash flow more than doubled to $156.6 million.

• Net sales increased 14.9% year-over-year to $3.25 billion.
• Gross margin expanded to 28.5%.

Jefferies' Q1 2025 results showed net revenue of $1.59 billion and net income attributable to common shareholders of $127.8 million. While Advisory and Debt Underwriting grew significantly, Equity Underwriting and Asset Management returns were weaker. The return on adjusted tangible equity stood at 8.0%.

• Total net revenues were $1.59 billion, down from $1.74 billion in Q1 2024.
• Net income attributable to common shareholders was $127.8 million, down from $149.6 million.

Alvotech reported record financial results for full year 2024, with total revenues reaching $492 million, a 427% increase over the prior year, and product revenues reaching $273 million, a 462% increase. The company achieved positive Adjusted EBITDA of $108.3 million, a significant improvement from a negative $291 million in 2023. Three new proposed biosimilars were submitted in major global markets in 2024, with all applications subsequently accepted by regulatory authorities.

• Total Revenues in 2024 reached $492 million, representing a 427% increase over prior year.
• Product Revenues in 2024 reached $273 million, representing a 462% increase over prior year.

H.B. Fuller Company reported first quarter fiscal 2025 results with net revenue of $789 million, down 2.7% year-on-year, primarily due to unfavorable foreign currency translation and the divestiture of the flooring business. Organic revenue, however, increased by 1.9% driven by improved volume. Net income was $13 million, and adjusted EBITDA was $114 million, a 7% decrease from the prior year, attributed to higher raw material costs and variable compensation.

• Net revenue for Q1 2025 was $789 million, a 2.7% decrease year-on-year.
• Organic revenue increased by 1.9% year-on-year, driven by improved volume.

Concentrix posted revenue of $2.37 billion in Q1 2025, down 1.3% year-over-year, but grew operating income by 13.8% and net income by 34.9%. The company exceeded its profit guidance and maintained strong margins, with EPS reaching $1.04 and non-GAAP EPS at $2.79.

• Revenue declined 1.3% year-over-year to $2.37 billion, but grew 1.3% on a constant currency basis.
• Operating income increased 13.8% to $168.9 million, and operating margin improved to 7.1%.

Verint reported Q4 2025 revenue of $253.5 million, down 4.4% from the prior year. Net income attributable to common shareholders was $28.8 million, with GAAP EPS at $0.45 and non-GAAP EPS at $0.99. The company saw a 30.3% year-over-year increase in SaaS ACV from new deals, reflecting strong momentum in AI-powered automation solutions.

• Q4 revenue decreased 4.4% year-over-year to $253.5 million.
• Net income attributable to common shareholders was $28.8 million.

MillerKnoll posted a small year-over-year revenue increase in Q3 FY2025, supported by strong Global Retail demand, particularly in North America. However, the quarter ended with a net loss primarily due to $130M in impairment charges. Adjusted EPS met expectations at $0.44.

• Consolidated revenue was $876.2M, up 0.4% year-over-year.
• Reported EPS was -$0.19; Adjusted EPS came in at $0.44.

Steelcase posted Q4 2025 revenue of $788.0 million, a 2% increase year-over-year. Net income rose to $27.6 million with GAAP EPS of $0.23 and adjusted EPS of $0.26. Gross margin improved to 31.9%, driven by cost reductions. However, operating income declined due to higher expenses and weaker international performance.

• Revenue grew 2% year-over-year to $788.0 million.
• Net income increased to $27.6 million from $21.3 million in Q4 2024.

JinkoSolar's Q4 2024 earnings showed a revenue decline of 37.1% year-over-year and a net loss of $64.9 million, largely due to falling solar module prices and lower overseas order contributions. Gross margin fell sharply to 3.6%. The company reported an adjusted net loss of $52.2 million and continues to navigate through industry imbalances with focus on technological advancements.

• Revenue decreased 37.1% year-over-year to $2,829,139,000.
• Gross margin declined significantly to 3.6%.

In Q4 2024, Petco's revenue declined by 7.3% year-over-year to $1.55 billion, while it narrowed its GAAP net loss to $13.8 million. Adjusted EBITDA was $96.1 million, reflecting a decrease from the prior year. Operating income improved significantly year-over-year, and gross profit experienced a smaller decline relative to revenue.

• Revenue fell 7.3% year-over-year to $1.55 billion due to the loss of a 53rd week in the prior year.
• GAAP net loss narrowed to $13.8 million compared to $22.6 million in Q4 2023.

Target Hospitality's Q4 2024 revenue decreased to $83.7 million, down from $126.2 million year-over-year. The company reported net income of $12.5 million and adjusted EBITDA of $41.1 million. The hospitality and facilities services segment showed stable performance, while the government segment faced significant reductions due to contract terminations and amortization effects.

• Q4 2024 revenue was $83.7 million, down 33.7% year-over-year.
• Net income for the quarter was $12.5 million.

The company experienced a year-over-year decline in revenue and net income in Q4 2024, primarily driven by lower product pricing. Gross profit was impacted but partially offset by decreased corn and natural gas prices and higher ethanol production volumes.

• Revenue for Q4 2024 was $158.2 million, down from $187.6 million in Q4 2023.
• Net income attributable to REX shareholders was $11.1 million, compared to $20.6 million last year.

Canaan delivered robust Q4 2024 results with revenue of $88.77 million, surpassing expectations, driven by record computing power sales and significant growth in mining revenue. Despite improvements in top-line performance and EBITDA turning positive, the company reported a net loss due to non-cash expenses and tax adjustments.

• Total revenue reached $88.77 million, up 80.9% year-over-year.
• Mining revenue soared to $15.30 million, a 312.5% increase year-over-year.

3D Systems' Q4 2024 revenue fell 3% year-over-year to $111 million, largely due to an $8.7 million adjustment tied to its Regenerative Medicine program. The company posted a net loss of $33.7 million and continued efforts to cut costs, while non-GAAP EPS came in at -$0.19.

• Q4 revenue declined 3% year-over-year to $111 million.
• Reported EPS was -$0.25; non-GAAP EPS was -$0.19.

In Q4 2024, MicroVision generated $1.7 million in revenue, down from the previous year primarily due to the absence of one-time Microsoft revenue. The company recorded a net loss of $31.2 million, impacted by a $13.2 million convertible note expense. Despite challenges, demand from industrial customers remained a positive sign.

• Q4 revenue was $1.7 million, down from $5.1 million in Q4 2023.
• Net loss widened to $31.2 million from $19.7 million in Q4 2023.

Zhihu achieved total revenue of $117,712,000 in Q4 2024, with net income of $11,838,000 and non-GAAP adjusted net income of $13,300,000. The company posted its first profitable quarter, driven by margin improvements and disciplined expense management.

• Total revenue was $117.7 million, down from $161.2 million year-over-year.
• Gross margin expanded to 62.9%, reflecting better monetization and efficiency.

The company reported no revenue for Q4 2024 and recorded higher research and development expenses year-over-year, contributing to a net loss of $15.4 million for the quarter. Leap continued advancing its clinical programs, with positive data from the DeFianCe study supporting future registrational trials.

• Leap reported no revenue for Q4 2024.
• R&D expenses for Q4 2024 increased to $13.1 million from $11.7 million in Q4 2023.

Journey Medical posted a surprise profit in Q4 2024, reversing previous losses. Revenue came in at $13.6M and the company reported net income of $1.5M, helped by lower R&D spend and tight SG&A management. The Emrosi launch remains a key catalyst for 2025.

• Journey posted net income of $1.5M in Q4 2024, reversing prior losses.
• Revenue for Q4 was $13.6M, bringing full-year revenue to $56.1M.

In Q4 2024, Zepp Health generated $59.5M in revenue, up 40% QoQ but down 28% YoY. Despite improved gross margin at 36.8%, a net loss of $36.9M was reported due to one-off non-cash provisions and investment losses.

• Revenue reached $59.5M in Q4, up 40% QoQ but down 28.3% YoY.
• Gross margin improved to 36.8%, driven by favorable product mix.

The company reported a significant decline in Q4 2024 revenues compared to the previous year, accompanied by increased research and development expenses as clinical activities accelerated. Net losses expanded, reflecting operational investments and decreased collaboration revenues.

• Revenue for Q4 2024 was $638,000, down from $7 million in Q4 2023.
• Net loss totaled $17.8 million for the quarter, compared to $16.3 million in Q4 2023.

The company reported Q4 2024 revenue of $5.6 million, down from $8.2 million in the prior year. Gross margin declined to 45% due to lower production volumes and inventory adjustments. Operating expenses were reduced significantly, contributing to a lower net loss compared to previous quarters.

• Q4 2024 revenue was $5.6 million, down from $8.2 million in Q4 2023.
• Gross profit margin decreased to 45%, impacted by lower volumes and inventory adjustments.